Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Cantor Fitzgerald
Fuji
Baxter
Teva
Mallinckrodt
Chubb
Moodys
Accenture

Generated: October 23, 2017

DrugPatentWatch Database Preview

Us Worldmeds Llc Company Profile

« Back to Dashboard

What is the competitive landscape for US WORLDMEDS LLC, and when can generic versions of US WORLDMEDS LLC drugs launch?

US WORLDMEDS LLC has three approved drugs.

There are three US patents protecting US WORLDMEDS LLC drugs.

There are seventy-six patent family members on US WORLDMEDS LLC drugs in thirty-one countries and seven supplementary protection certificates in six countries.

Summary for Applicant: Us Worldmeds Llc

International Patents:76
US Patents:3
Tradenames:3
Ingredients:3
NDAs:3
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Worldmeds Llc
XADAGO
safinamide mesylate
TABLET;ORAL207145-002Mar 21, 2017RXYesYes► Subscribe► SubscribeY ► Subscribe
Us Worldmeds Llc
XADAGO
safinamide mesylate
TABLET;ORAL207145-001Mar 21, 2017RXYesNo► Subscribe► Subscribe ► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-005Oct 28, 1986ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Worldmeds Llc
XADAGO
safinamide mesylate
TABLET;ORAL207145-002Mar 21, 2017RXYesYes► Subscribe► SubscribeYY ► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Worldmeds Llc
XADAGO
safinamide mesylate
TABLET;ORAL207145-001Mar 21, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Worldmeds Llc
XADAGO
safinamide mesylate
TABLET;ORAL207145-001Mar 21, 2017RXYesNo► Subscribe► SubscribeYY ► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Worldmeds Llc
ZELNORM
tegaserod maleate
TABLET;ORAL021200-002Jul 24, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Us Worldmeds Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Worldmeds Llc
ZELNORM
tegaserod maleate
TABLET;ORAL021200-001Jul 24, 2002► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-005Oct 28, 1986► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
CORGARD
nadolol
TABLET;ORAL018063-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Worldmeds Llc
ZELNORM
tegaserod maleate
TABLET;ORAL021200-002Jul 24, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Us Worldmeds Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,901,176Methods for treatment of Parkinson's disease► Subscribe
9,492,410Methods for treatment of Parkinson's disease► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Us Worldmeds Llc Drugs

Country Document Number Estimated Expiration
South Korea20060010745► Subscribe
South Korea101410291► Subscribe
BrazilPI0409364► Subscribe
Mexico342698► Subscribe
Slovenia1613296► Subscribe
Austria435012► Subscribe
Canada2653012► Subscribe
Taiwan200815322► Subscribe
China103284984► Subscribe
European Patent Office2474521► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Us Worldmeds Llc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00042Denmark► SubscribePRODUCT NAME: KOMBINATION AF SAFINAMID, HERUNDER SAFINAMID METHANSULFONAT, OG LEVODOPA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150226
782Luxembourg► SubscribePRODUCT NAME: SAFINAMIDE A UTILISER EN COMBINAISON AVEC LEVODOPA/PDI, ET EVENTUELLEMENT AVEC D'AUTRES MEDICAMENTS PD , POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON; FIRST REGISTRATION DATE: 20150224
1 50017-2015Slovakia► SubscribePRODUCT NAME: SAFINAMID; REGISTRATION NO/DATE: EU/1/14/984/001 - EU/1/14/984/010 20150226
0752Netherlands► SubscribePRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
2015 00042Denmark► SubscribePRODUCT NAME: KOMBINATION AF SAFINAMID OG LEVOPODA/PDI; REG. NO/DATE: EU/1/14/984/001-010 20150224
/2015Austria► SubscribePRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
0505322/01Switzerland► SubscribePRODUCT NAME: TEGASEROD; REGISTRATION NO/DATE:IKS 55689 20011030
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
McKesson
Argus Health
Accenture
AstraZeneca
McKinsey
Chubb
Julphar
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot